Topic: East Asia

China has sentenced to death the former president of state-owned Shanghai Pharmaceutical Group for corruption, state media said Wednesday, in a case that has fuelled concerns over drug safety.A Shanghai court on Tuesday sentenced Wu Jianwen, 42, to death with a two-year ...

Hong Kong has ordered pharmaceutical giant GlaxoSmithKline to recall an antibiotic which contained chemical additives, and warned it may take legal action against the manufacturer.The health department said tests revealed the British-based firm's Augmentin antibiotic tablet contained several plasticisers, including diisodecyl phthalate ...

Hong Kong has ordered pharmaceutical giant GlaxoSmithKline to recall an antibiotic used to treat infections in children which contained chemical additives, and warned it may sue the drugmaker.The health department on Monday said tests revealed the British firm's Augmentin antibiotic tablet contained ...

Taiwan has ordered pharmaceutical giant GlaxoSmithKline to recall an antibiotic used to treat infections in children for containing a chemical additive, a report said Saturday.The Department of Health was prompted to order the recall of Augmentin antibiotic syrup produced following a similar ...

Hong Kong has ordered pharmaceutical giant GlaxoSmithKline to recall an antibiotic used to treat infections in children which contained a chemical additive twice recommended European safety limits.A government spokesman said Friday that tests revealed the Augmentin antibiotic syrup produced by the British ...

Japan's Takeda Pharmaceutical said Thursday it reached a 9.6 billion euro ($13.6 billion) deal to buy Swiss drugmaker Nycomed in what would be one of the biggest overseas acquisitions by a Japanese firm.Takeda said it will finance part of the transaction through ...

TOKYO (Reuters) - Japan's largest drugmaker Takeda Pharmaceutical Co is in talks to buy privately-held Swiss rival Nycomed in a deal that could be valued at about $14.2 billion, Bloomberg said, citing two people with knowledge of the matter.Negotiations are at an ...

BEIJING (Reuters) - Drugmaker Eli Lilly , which faces plunging sales due to competition and lapsing patents, will not merge with another peer to ride out any rough times ahead, chief executive John Lechleitr said on Saturday.Speaking on the sidelines of a ...

South Korea's biggest business group Samsung announced plans Friday for a $266 million pharmaceutical joint venture, as part of a ten-year multi-billion dollar attempt to develop new growth engines.Samsung said work would start in the first half of this year on a ...

LONDON (Reuters) - China is set to become the world's most important center for innovation by 2020, overtaking both the United States and Japan, according to a public opinion survey to be published on Monday.China is already the world's second-largest economy, after ...